The role of Pitx3 in survival of midbrain dopaminergic neurons

  • S. M. Smits
  • M. P. Smidt
Conference paper

DOI: 10.1007/978-3-211-45295-0_10

Part of the Journal of Neural Transmission. Supplementa book series (NEURALTRANS, volume 70)
Cite this paper as:
Smits S.M., Smidt M.P. (2006) The role of Pitx3 in survival of midbrain dopaminergic neurons. In: Riederer P., Reichmann H., Youdim M.B.H., Gerlach M. (eds) Parkinson’s Disease and Related Disorders. Journal of Neural Transmission. Supplementa, vol 70. Springer, Vienna

Summary

Dopamine belongs to the most intensively studied neurotransmitters of the brain, because of its implications in psychiatric and neurological disorders. Although, clinical relevance of midbrain dopaminergic (mDA) neurons is well recognized and dopaminergic dysfunction may have a genetic component, the genetic cascades underlying developmental processes are still largely unknown. With the advances in molecular biology, mDA neurons and their involvement in psychiatric and neurological disorders are now subject of studies that aim to delineate the fundamental neurobiology of these neurons. These studies are concerned with developmental processes, cell-specific gene expression and regulation, molecular pharmacology, and genetic association of dopamine-related genes and mDAassociated disorders. Several transcription factors implicated in the post-mitotic mDA development, including Nurr1, Lmx1b, Pitx3, and En1=En2 have contributed to the understanding of how mDA neurons are generated in vivo. Furthermore, these studies provide insights into new strategies for future therapies of Parkinson’s Disease (PD) using stem cells for engineering DA neurons in vitro. Here, we will discuss the role of Pitx3 in molecular mechanisms involved in the regional specification, neuronal specification and differentiation of mDA neurons.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • S. M. Smits
    • 1
  • M. P. Smidt
    • 1
  1. 1.Rudolf Magnus Institute of Neuroscience, Department of Pharmacology and AnatomyUniversity Medical Center UtrechtUtrechtThe Netherlands

Personalised recommendations